Showing results (2261-2270 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|April 18, 2021
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machineryMichihisa Kono, Takumi Kumai, Ryusuke Hayashi, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Distribution of intact and Fab2(1) fragments of anti-human chorionic gonadotrophin antibodies in nude mice bearing human choriocarcinoma xenograftsF Searle, T Adam, J A Boden
Cancer Immunology, Immunotherapy : CII|August 31, 2002
Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune responseChristiane Wack, Annette Kirst, Jürgen C Becker, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2002
Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatantsA D Gritzapis, D Dimitroulopoulos, E Paraskevas, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2003
Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progressionClaudio Gambini, Angela Rita Sementa, Luca Boni, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2003
A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancerAnand G Menon, Gert Jan Fleuren, Ellen A Alphenaar, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2003
Amifostine protects lymphocytes during radiotherapy and stimulates expansion of the CD95/Fas and CD31 expressing T-cells, in breast cancer patientsMichael I Koukourakis, Sophia Ktenidou-Kartali, George Bourikas, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Analysis of HLA expression in human tumor tissuesTeresa Cabrera, Miguel Angel López-Nevot, Jose Juan Gaforio, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2003
Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancySuzanne Norris, Derek G Doherty, Michael Curry, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2002
Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma modelPablo Matar, Viviana R Rozados, Silvia I Gervasoni, et al.
Pageof 652